Healthcare & Life Sciences

A new partnership in LA sees a healthcare giant funding education. It’s not charity—it's a strategic bet on a new economic model for American healthcare.

In a county grappling with food insecurity, a new program delivers health through groceries. Here's how the Umoja-OCO partnership redefines care.

MedPro Systems' new EngagePro platform aims to replace operational chaos with structured governance for HCP engagements. But can it truly de-risk a complex industry?

Six months of job growth from small firms paint a picture of resilience, but a closer look reveals a split reality, with healthcare booming and hospitality cooling.

With a 3.2 million worker shortage looming, a new investment in online trainer ACT reveals how private equity plans to scale a tech-driven solution.

Sage Dental's major acquisition in Tampa isn't just a deal; it's a look into the future of healthcare—a story of scale, strategy, and the test of local trust.

A strategic acquisition, backed by Monroe Capital, is set to expand vital pediatric therapy training, revealing how private credit fuels innovation in niche healthcare.

A little-known lung disease is on the rise, with diagnoses delayed for years. We explore why NTM is a growing public health challenge and how awareness is key.

A new study claims nearly half of Medicaid expansion enrollees are ineligible. Is this a fiscal crisis or a distraction from a vital safety net?

As Sonida Senior Living prepares its Q2 results, investors are watching closely. Can the operator prove its massive merger is paying off amidst industry-wide cost pressures?

As Continual-G expands across the US with bold scientific claims, it highlights a growing trend and a critical question: is this the future of wellness, or just for the wealthy?

A surgeon's identity was stolen by AI to sell fake cures. His testimony before Congress reveals a new frontier of fraud threatening patient safety.

As corporate buyers reshape healthcare, a new guide urges independent doctors to control their destiny by understanding their practice's true value and exit options.

A landmark study reveals a chasm between demand and access for First Peoples' cultural medicines, challenging Australia's health system to move beyond tokenism.

Celebrities are flocking to the world's largest Down syndrome fundraiser, but the real headline is the result: a 10-year leap in lifespan driven by strategic science.

Blue Sea Capital's oversubscribed deal for One Physics isn't just a transaction; it's a playbook for a new era in private equity and healthcare services.

With a new CEO for operations and an Executive Chairman for M&A, Kalon Aesthetics is executing a playbook aimed at rapid consolidation in the booming aesthetics market.

Autism care provider BlueSprig made TIME's new 'Best Private Companies' list. The real story is how it reveals a new metric for success beyond profit.

A landmark lawsuit in Brazil isn't just about tobacco; it's a stress test for the global network of corporate accountability and public health funding.

A unique partnership is rewiring Kingston’s approach to child wellness. It’s not a top-down mandate, but a new operating system for urban health infrastructure.